Literature DB >> 22824264

Computational analysis of the regulation of EGFR by protein tyrosine phosphatases.

Calixte S Monast1, Christopher M Furcht, Matthew J Lazzara.   

Abstract

The tyrosine phosphorylated epidermal growth factor receptor (EGFR) initiates numerous cell signaling pathways. Although EGFR phosphorylation levels are ultimately determined by the balance of receptor kinase and protein tyrosine phosphatase (PTP) activities, the kinetics of EGFR dephosphorylation are not well understood. Previous models of EGFR signaling have generally neglected PTP activity or computed PTP activity by considering data that do not fully reveal the kinetics and compartmentalization of EGFR dephosphorylation. We developed a compartmentalized, mechanistic model to elucidate the kinetics of EGFR dephosphorylation and the coupling of this process to phosphorylation-dependent EGFR endocytosis. Model regression against data from HeLa cells for EGFR phosphorylation response to EGFR activation, PTP inhibition, and EGFR kinase inhibition led to the conclusion that EGFR dephosphorylation occurs at the plasma membrane and in the cell interior with a timescale that is smaller than that for ligand-mediated EGFR endocytosis. The model further predicted that sufficiently rapid dephosphorylation of EGFR at the plasma membrane could potentially impede EGFR endocytosis, consistent with recent experimental findings. Overall, our results suggest that PTPs regulate multiple receptor-level phenomena via their action at the plasma membrane and cell interior and point to new possibilities for targeting PTPs for modulation of EGFR dynamics.
Copyright © 2012 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22824264      PMCID: PMC3341563          DOI: 10.1016/j.bpj.2012.03.037

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  40 in total

1.  Perinuclear localization of the protein-tyrosine phosphatase SHP-1 and inhibition of epidermal growth factor-stimulated STAT1/3 activation in A431 cells.

Authors:  T Tenev; S A Böhmer; R Kaufmann; S Frese; T Bittorf; T Beckers; F D Böhmer
Journal:  Eur J Cell Biol       Date:  2000-04       Impact factor: 4.492

2.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors.

Authors:  Birgit Schoeberl; Claudia Eichler-Jonsson; Ernst Dieter Gilles; Gertraud Müller
Journal:  Nat Biotechnol       Date:  2002-04       Impact factor: 54.908

3.  Mathematical models of protein kinase signal transduction.

Authors:  Reinhart Heinrich; Benjamin G Neel; Tom A Rapoport
Journal:  Mol Cell       Date:  2002-05       Impact factor: 17.970

4.  Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis.

Authors:  Birgit Schoeberl; Emily A Pace; Jonathan B Fitzgerald; Brian D Harms; Lihui Xu; Lin Nie; Bryan Linggi; Ashish Kalra; Violette Paragas; Raghida Bukhalid; Viara Grantcharova; Neeraj Kohli; Kip A West; Magdalena Leszczyniecka; Michael J Feldhaus; Arthur J Kudla; Ulrik B Nielsen
Journal:  Sci Signal       Date:  2009-06-30       Impact factor: 8.192

5.  ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.

Authors:  Alan E Wakeling; Simon P Guy; Jim R Woodburn; Susan E Ashton; Brenda J Curry; Andrew J Barker; Keith H Gibson
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

6.  Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutations.

Authors:  Matthew J Lazzara; Keara Lane; Richard Chan; Paul J Jasper; Michael B Yaffe; Peter K Sorger; Tyler Jacks; Benjamin G Neel; Douglas A Lauffenburger
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

Review 7.  Protein tyrosine phosphatases: dephosphorylating the epidermal growth factor receptor.

Authors:  Tony Tiganis
Journal:  IUBMB Life       Date:  2002-01       Impact factor: 3.885

8.  Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum.

Authors:  Fawaz G Haj; Peter J Verveer; Anthony Squire; Benjamin G Neel; Philippe I H Bastiaens
Journal:  Science       Date:  2002-03-01       Impact factor: 47.728

9.  Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction.

Authors:  A R French; D K Tadaki; S K Niyogi; D A Lauffenburger
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

10.  An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis.

Authors:  Gabi Tarcic; Shlomit K Boguslavsky; Jean Wakim; Tai Kiuchi; Angela Liu; Felicia Reinitz; David Nathanson; Takamune Takahashi; Paul S Mischel; Tony Ng; Yosef Yarden
Journal:  Curr Biol       Date:  2009-11-17       Impact factor: 10.834

View more
  15 in total

Review 1.  Cell signaling regulation by protein phosphorylation: a multivariate, heterogeneous, and context-dependent process.

Authors:  Evan K Day; Nisha G Sosale; Matthew J Lazzara
Journal:  Curr Opin Biotechnol       Date:  2016-07-06       Impact factor: 9.740

Review 2.  An engineering design approach to systems biology.

Authors:  Kevin A Janes; Preethi L Chandran; Roseanne M Ford; Matthew J Lazzara; Jason A Papin; Shayn M Peirce; Jeffrey J Saucerman; Douglas A Lauffenburger
Journal:  Integr Biol (Camb)       Date:  2017-07-17       Impact factor: 2.192

Review 3.  The Dark Side of Cell Signaling: Positive Roles for Negative Regulators.

Authors:  Mark A Lemmon; Daniel M Freed; Joseph Schlessinger; Anatoly Kiyatkin
Journal:  Cell       Date:  2016-03-10       Impact factor: 41.582

4.  GP78 Cooperates with Dual-Specificity Phosphatase 1 To Stimulate Epidermal Growth Factor Receptor-Mediated Extracellular Signal-Regulated Kinase Signaling.

Authors:  Dhong Hyo Kho; Mohammed Hafiz Uddin; Madhumita Chatterjee; Andreas Vogt; Avraham Raz; Gen Sheng Wu
Journal:  Mol Cell Biol       Date:  2019-05-14       Impact factor: 4.272

5.  The AXL Receptor is a Sensor of Ligand Spatial Heterogeneity.

Authors:  Aaron S Meyer; Annelien J M Zweemer; Douglas A Lauffenburger
Journal:  Cell Syst       Date:  2015-07-29       Impact factor: 10.304

6.  Identifying Determinants of EGFR-Targeted Therapeutic Biochemical Efficacy Using Computational Modeling.

Authors:  C S Monast; M J Lazzara
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-10-15

7.  Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes.

Authors:  Elizabeth Bloch; Eden L Sikorski; David Pontoriero; Evan K Day; Bryan W Berger; Matthew J Lazzara; Damien Thévenin
Journal:  J Biol Chem       Date:  2019-11-01       Impact factor: 5.486

8.  Single Particle Tracking Reveals that EGFR Signaling Activity Is Amplified in Clathrin-Coated Pits.

Authors:  Jenny Ibach; Yvonne Radon; Márton Gelléri; Michael H Sonntag; Luc Brunsveld; Philippe I H Bastiaens; Peter J Verveer
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

9.  PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2.

Authors:  H Dong; L Ma; J Gan; W Lin; C Chen; Z Yao; L Du; L Zheng; C Ke; X Huang; H Song; R Kumar; S C Yeung; H Zhang
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

10.  Quantitative analysis reveals how EGFR activation and downregulation are coupled in normal but not in cancer cells.

Authors:  Fabrizio Capuani; Alexia Conte; Elisabetta Argenzio; Luca Marchetti; Corrado Priami; Simona Polo; Pier Paolo Di Fiore; Sara Sigismund; Andrea Ciliberto
Journal:  Nat Commun       Date:  2015-08-12       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.